Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leaning, Darren
ADAPT-P, NCT06019676: Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients	Recruiting	N/A	170	Europe		Royal Marsden NHS Foundation Trust, Janssen, LP	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	04/27	04/27
Elliott, Claire
ADAPT-P, NCT06019676: Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients	Recruiting	N/A	170	Europe		Royal Marsden NHS Foundation Trust, Janssen, LP	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	04/27	04/27
Keith, Sarah
ADAPT-P, NCT06019676: Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients	Recruiting	N/A	170	Europe		Royal Marsden NHS Foundation Trust, Janssen, LP	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	04/27	04/27